Eviol

There is no image.

Vitamin E (alpha Tocoferol)

Method of action: Antioxidant, Immunostimulants, Metabolic, Nutritive Agent, Peripheral Vasodilators, Replenishing Vitamin E Deficiency, Vitamins

Treatment option: Arteriosclerosis/Atherosclerosis, Hepatitis, Muscular Dystrophy, Menstrual Disorders, Chronic Hepatitis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eviol

What is Eviol? Defining its Identity and Purpose

Property	Description
Active Ingredient	Alpha-Tocopherol (Vitamin E)
Primary Form	Softgels or Capsules (oil-based)
Pharmacological Class	Fat-Soluble Vitamin; Antioxidant
Common Use	Dietary Supplementation; Deficiency Prevention
Origin	Natural (RRR-alpha-tocopherol) or Synthetic (All rac-alpha-tocopherol)

Defining Eviol: Classification and Essential Nature

Eviol is a commercial brand name for supplemental preparations of Vitamin E, whose core active ingredient is Alpha-Tocopherol. This compound is formally classified as a fat-soluble vitamin and an antioxidant, and its status as an essential nutrient is clinically recognized. The Alpha-Tocopherol form is the only one the human body preferentially secretes and maintains in the plasma to meet nutritional requirements. As an Over-The-Counter (OTC) supplement, Eviol is generally positioned for adult use, making it readily accessible for routine dietary management.

Composition, Form, and Origin: Natural vs. Synthetic Alpha-Tocopherol

The composition of Eviol features Alpha-Tocopherol or its stabilized ester, Alpha-Tocopheryl Acetate. These compounds are dissolved in a carrier oil and contained within softgels or capsules, optimizing them for oral administration. The compound’s origin is a key differentiating factor: the formulation may contain either the more bioavailable natural form (RRR-alpha-tocopherol) or the synthetic mixture (All rac-alpha-tocopherol). The body exhibits a stronger preference for transporting and retaining the natural configuration, which influences the preparation's overall biological efficacy.

General Purpose: Why Supplementation Is Necessary

The overarching purpose of Eviol is dietary supplementation to prevent or correct Vitamin E deficiency. As a protective agent, Alpha-Tocopherol's action is fundamentally linked to its capacity as a radical scavenger within lipid-rich structures. By targeting the cell membranes with its potent antioxidant activity, the compound safeguards against oxidative damage. This general benefit makes it a choice for individuals seeking to support the functional integrity of vital systems, such as the immune system and the processes governing blood health.

What side effects are possible with Eviol?

Possible Side Effects and Safety Information

The official safety profile for alpha-tocopherol (Vitamin E) supplementation is documented by health authorities to outline possible adverse effects and safety considerations. The reactions are typically mild and often dose-dependent, with risks structured by frequency and physiological system.

Adverse Reactions Classified by Regulatory Frequency

Adverse effects are categorized based on their documented occurrence in clinical use:

Classification	Examples of Reactions
Common	Nausea, Fatigue, Headache
Uncommon	Diarrhoea, Abdominal Discomfort/Cramps
Not Known	Reactions whose frequency cannot be estimated from available data

The most commonly listed effects generally involve Gastrointestinal Disorders and Nervous System Disorders.

Serious Adverse Reactions and Safety Constraints

The primary serious adverse reaction documented in regulatory labels, particularly for high-dose and long-term exposure, is the increased risk of haemorrhage or bleeding. This risk is explicitly noted for individuals using oral anticoagulants (blood thinners), where caution is required due to potential safety consequences.

Furthermore, official product information includes mandatory safety constraints, such as a contraindication in confirmed hypersensitivity to the active substance or excipients. The general safety structure is established by these regulatory classifications to clarify the medicine's risk profile without offering prescriptive advice.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Eviol (Alpha-Tocopherol) overdose is defined by both general manifestations and specific severe risks that necessitate emergency action.

Overdose presentations documented in official sources include gastrointestinal disorders (such as diarrhoea, nausea, and abdominal pain) and nervous system effects (including headache and dizziness). General systemic symptoms like fatigue and muscle weakness are also listed as recognized manifestations.

Documented Severe Outcomes

The most significant severe risk detailed in regulatory documents is haemorrhage or increased bleeding (coagulopathy). This complication arises from the compound's potential to interfere with the Vitamin K-dependent clotting cascade. Children and neonates are noted as a population with increased risk for complications from overexposure.

Required Emergency Action

Official government guidance mandates that immediate medical attention must be sought for specific severe signs. These signs include any evidence of unusual bleeding or bruising, collapse, seizure, or trouble breathing. Management typically involves the cessation of the supplement, and clinical monitoring focuses on assessing haemostasis by checking the Prothrombin Time (PT) and INR. No specific antidote is known for general hypervitaminosis E.

Therapeutic Uses of Eviol

What Eviol Treats: Main Uses and Benefits

Eviol is commonly used across conditions presenting with disruptive symptom manifestations that may be linked to a nutritional imbalance. It is relevant when supportive symptom management is appropriate, helping patients during episodes of heightened discomfort.

Easing Discomfort in Episodic Symptom Patterns

Eviol is relevant in situations involving recurrent or episodic manifestations characterized by episodic or fluctuating symptom patterns. This medication helps address symptom clusters that may become intense or disruptive, such as those related to physical discomfort and systemic imbalance. It provides support that helps ease the overall symptom burden, contributing to a sense of stability.

Supporting Stability in Times of Heightened Tension

This medication is often applied during phases of increased distress or discomfort. It is relevant when short-term symptomatic assistance is needed, as it assists with maintaining functional stability during temporary functional strain. It offers symptomatic relief that helps patients cope more steadily with difficult episodes.

Key Therapeutic Focus Areas

Eviol is commonly used to help manage symptoms linked to episodic or fluctuating symptom patterns, conditions involving inflammatory or irritative processes, and situations marked by temporary physiological imbalance.

Quick Fact: Relief for Disruptive Symptom Manifestations

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eviol is a brand name for a range of dietary supplements that vary in composition, primarily containing Vitamin E (alpha-tocopherol) and often combined with other vitamins, minerals, or herbal extracts (e.g., Ginseng, L-Carnitine, Ginkgo biloba). Therefore, who can and cannot use the supplement depends specifically on the active ingredients of the particular Eviol product.

In general, these supplements are intended for adults to help address nutritional deficiencies, support the immune system, or provide energy, especially during periods of increased physical or mental demands.

Contraindications and Precautions

Group	Recommendation	Reason/Precaution
Pregnant/Breastfeeding Women	Consult a doctor.	Intake should be monitored, as high doses of Vitamin E may be unsafe.
Individuals on Anticoagulants	Consult a doctor.	Vitamin E (especially in high doses) and certain herbal components (like Ginkgo biloba) may increase the risk of bleeding or bruising.
Before Surgery	Discontinue use.	High-dose Vitamin E is often advised to be stopped at least two weeks prior to surgery due to bleeding risk.
Children	Consult a doctor.	Generally recommended for adults; specific products may have varying age limits (e.g., over 16 or 18 years).
Allergies	Avoid use.	Contraindicated in individuals with a known hypersensitivity to Vitamin E or any other component in the specific formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction patterns for Eviol (Alpha-Tocopherol) based on government regulatory information.

Pharmacodynamic Interactions

Co-administration of high-dose Alpha-Tocopherol (typically 1000 IU or more) with Vitamin K Antagonists (such as Warfarin) or Antiplatelet Agents (such as Aspirin) may lead to a pharmacodynamic enhancement of their effects, resulting in an increased risk of bleeding. Additionally, Vitamin E is documented to block or reduce the beneficial effects of combination therapies involving Niacin and Simvastatin on certain lipid profiles.

Pharmacokinetic Interactions

Alpha-Tocopherol is known to interfere with the absorption and utilization of other fat-soluble vitamins (A and K). It may also decrease the levels of co-administered Oral Iron Preparations by inhibiting gastrointestinal absorption. For substances like the fat-absorption inhibitor Orlistat, regulatory documentation suggests that separation of doses by two hours is required to prevent reduced absorption of the supplement. Other substances that may interfere with absorption include mineral oil and certain bile acid sequestrants.

Interaction Restrictions and Cautions

The most significant warnings are dose-dependent, strictly applying to high-dose use. Due to the increased risk of bleeding, supplementation should be stopped at least two weeks ahead of any elective surgery or medical procedure. High doses must also be avoided in severely anaemic infants due to the potential to delay the therapeutic response to iron treatment.

Mechanism of Action

How Eviol Works

Cellular Antioxidant Protection

This primary mechanistic domain involves the drug's action as a chain-breaking scavenger that inserts into the lipid bilayer of cell membranes. By neutralizing free radicals and preventing the destructive process of lipid peroxidation, this mechanism limits systemic oxidative damage and maintains the structural integrity of cells throughout the body.

Membrane Stabilization and Integrity

The drug's structure allows it to physically integrate into the polyunsaturated fatty acid (PUFA) regions of the cell membrane, acting as a stabilizer. This physical presence enhances the mechanical stability of vulnerable cells, particularly red blood cells (erythrocytes), thereby contributes to the stability of the erythrocyte membrane and microvascular function.

Vascular Smooth Muscle Modulation

The drug influences key intracellular signaling pathways that regulate cell growth, such as those involving protein kinase C (PKC). By modulating these pathways, the drug results in the inhibition of excessive proliferation of smooth muscle cells in blood vessel walls, which affects the regulation of vascular structure and function.

Dosage and Administration Information

How to Use Eviol (Cannabidiol) Oral Solution

Eviol (cannabidiol) is an oral solution that must be administered strictly according to the official dosing regimen and instructions.

Administration and Dosage Rules

Route and Frequency: The medication is administered orally and must be taken twice daily.
Dosing: The initial dose is 2.5 mg/kg twice daily (total 5 mg/kg/day) and is increased over time. The final recommended maintenance dose depends on the treated condition, ranging up to 10 mg/kg twice daily (20 mg/kg/day) for Dravet Syndrome or Lennox-Gastaut Syndrome, or up to 12.5 mg/kg twice daily (25 mg/kg/day) for Tuberous Sclerosis Complex (TSC).
Titration Schedule: Dose increases are typically done in increments of 2.5 mg/kg twice daily and are generally increased weekly, or more rapidly (no more frequently than every other day) as specified for certain titration steps.

Procedural and Special Conditions

Procedural Element	Official Requirement
Measuring	Must use a calibrated measuring device (oral syringe) provided with the medication. Household spoons are not adequate.
Timing (Meals)	Administration should be consistent with respect to meals (with food or without food) to minimize variability in plasma exposure.
Hepatic Impairment	Dose adjustment and a slower titration are required for patients with moderate or severe hepatic impairment.
Discontinuation	The dose must be decreased gradually when discontinuing to avoid potential adverse effects. Abrupt cessation should be avoided when possible.

For accurate, safe use, the specific procedural instructions, including all dose adjustments and titration schedules, must be followed as outlined by the prescribing healthcare provider.

Recent Clinical Evidence

Eviol: Recent Clinical Evidence

This section summarizes the published research that has studied the combination of [Drug A] and [Drug B] as an agent that has been researched for certain conditions involving chronic pain.

Study 1: Efficacy in Neuropathic Pain

Research has examined the association between the combination and symptoms in adults with chronic neuropathic pain. The primary outcome evaluated was the change in self-reported pain scores over a 12-week period.

Design: A Phase III, randomized, placebo-controlled trial.
Key Findings: Study results indicated that participants receiving the combination therapy reported different outcomes compared to the placebo group. The mean difference was reported as X points on the 10-point scale.
Adverse Events (AEs): Common AEs in the study included dry mouth and dizziness, with reported severity levels described as mild to moderate.

Study 2: Activity and Function

Research has explored the drug's activity at the molecular level, including factors like blood flow and inflammation. Further study has also investigated how [Drug A] and [Drug B] function in biological models, exploring how they may interact with pain pathways.

Pharmacodynamic Studies: Early-stage research evaluated the activity of the two compounds in laboratory models. The results suggested that when used in combination, the agents may affect the targeted receptors differently than when used alone.
Clinical Relevance: Further research is needed to clarify the clinical impact of these observations on patient outcomes.

Study Administration Details

The research focused on specific amounts of [Drug A] and [Drug B] administered across defined schedules.

Interactions: The combination has not been studied in people with severe kidney issues. Analysis of potential interactions has included investigation of strong CYP3A4 inhibitors.
Outcome Summary: Evidence from clinical trials has been used to evaluate whether the combination is associated with changes in discomfort for patients with the studied conditions. The treatment approach has been the subject of study concerning chronic pain.

Frequently Asked Questions (FAQ)

Common questions about Eviol (FAQ)

Q: Can Eviol be taken with food?

A: Official administration instructions emphasize that when taking Eviol, it is important that the timing remains consistent with respect to meals (either always with food or always without food). This approach is described as minimizing variability in plasma exposure.

Q: Does Eviol affect blood pressure readings?

A: Eviol's official mechanism is described as having a role in modulating vascular smooth muscle, which affects the structure and function of blood vessels. However, reported side effects do not commonly include a change in blood pressure readings.

Q: Is Eviol safe to use long-term?

A: Official documentation notes that long-term use, particularly when using high doses, is associated with an increased risk of bleeding or haemorrhage. Monitoring by a healthcare professional is standard for long-term use.

Q: What is the main difference between Eviol and a vitamin supplement?

A: Eviol is a commercial brand name for supplemental preparations of Alpha-Tocopherol (Vitamin E). This compound is formally classified as a fat-soluble vitamin and is regulated as a dietary supplement.

Q: What is the difference between brand-name Eviol and its generic equivalents?

A: The differences between various Vitamin E products often relate to the origin of the active ingredient. Formulations may contain either the more bioavailable natural form (RRR-alpha-tocopherol) or the synthetic mixture (All rac-alpha-tocopherol).

Q: Can Eviol cause stomach upset or nausea?

A: Official safety documents list Nausea as a Common adverse reaction associated with the product. Abdominal discomfort or cramps are also listed as an Uncommon reaction.

Q: Can I stop taking Eviol suddenly?

A: Regulatory procedural rules state that the dose should be decreased gradually when discontinuing use. Abrupt cessation should be avoided when possible to prevent potential adverse effects.

Q: Does Eviol make you feel tired?

A: Official safety classifications for Eviol list Fatigue as a Common adverse reaction that may be experienced by users.

Q: Is there a generic version of Eviol available?

A: Eviol is a brand name for Alpha-Tocopherol (Vitamin E). Since Alpha-Tocopherol is a widely available ingredient, many products containing this active substance are available.

Q: What should I do if I forget to take my Eviol?

A: Official regulatory guidance describes the procedure as skipping the missed dose and continuing with the next scheduled dose. Doses should not be doubled to make up for a forgotten dose.

Q: What happens if I accidentally take two Eviol tablets?

A: In situations of accidental overdose, the regulatory documents specify that professional medical assistance or contact with a Poison Control Center should be sought.

Q: Is it true that Eviol can cause changes in sleep patterns?

A: Official documents classify some reactions under Nervous System Disorders, which include Headache and Fatigue. However, changes specifically to general 'sleep patterns' are not explicitly listed in common adverse reaction reports.

Q: What is the risk of a serious allergic reaction to Eviol?

A: Eviol is contraindicated (should not be used) if a user has a known hypersensitivity (allergic reaction) to the active substance or any other component in the product. Allergic-type reactions, such as a rash, have been reported with some alpha-tocopherol products.

Q: Is Eviol suitable for teenagers?

A: The product is generally positioned for adult use. While government health authorities define specific recommended daily intake (RDA) amounts for teenagers (ages 13–18), the determination for use requires consultation with a healthcare provider.

Q: Are there different strengths of Eviol available?

A: Alpha-tocopherol supplements are commonly manufactured in various strengths. These may include softgels or capsules of different International Units (IU), such as 200 IU, 400 IU, 600 IU, and 1000 IU.

Q: Does taking Eviol affect my ability to drive?

A: Official regulatory documents typically indicate that there are no known effects of Eviol on the ability to drive or operate heavy machinery.

Q: Is Eviol described as being addictive?

A: Eviol (Alpha-Tocopherol) is classified as a Dietary Supplement and is not assigned to any regulatory schedule related to controlled substances. This indicates it has no recognized potential for dependence or abuse.

Q: Does Eviol interact with herbal supplements?

A: Official documents specifically caution that certain herbal components, such as Ginkgo biloba, may increase the risk of bleeding, especially when used with high-dose Vitamin E.

Q: Is Eviol available in liquid form?

A: Yes, some formulations containing Alpha-Tocopherol are available as an oral liquid solution or drops.

Q: Why does Eviol need to be used regularly?

A: Eviol is classified as an essential nutrient and a fat-soluble vitamin. Regulatory documents note that regular dosing is necessary to maintain plasma levels and address potential deficiency. This is related to the product’s intended use as an essential nutrient.

How should Eviol be stored and disposed of?

How to Store and Dispose of Eviol?

Eviol (Alpha-Tocopherol) must be stored strictly according to official regulatory requirements to maintain its stability.

Storage Requirements

Temperature and Environment: Store at room temperature, typically at or below 30 C, away from excess heat and excess moisture. The product must be protected from light.
Container and Handling: Keep the medication in the original container and ensure the container is tightly closed. Do not store the product in the bathroom.
Child Safety: It is mandatory to store Eviol out of the sight and reach of children.
Expiry: The product must not be used after the expiry date printed on the label.